If we get thru to P3 $10 SP minimum - I think it will be a lot higher as it will open the door to ROW and all the other indications the company is working with NNZ 2591.
MOO DYOR GLA
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 3 enrolment successfully completed, results in Q4 2021
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.00%
!
$13.24

Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.24 |
Change
0.385(3.00%) |
Mkt cap ! $1.626B |
Open | High | Low | Value | Volume |
$13.15 | $13.34 | $12.92 | $3.743M | 285.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 59 | $13.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.24 | 97 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 127 | 13.230 |
3 | 135 | 13.220 |
5 | 581 | 13.210 |
5 | 705 | 13.200 |
6 | 1263 | 13.190 |
Price($) | Vol. | No. |
---|---|---|
13.240 | 128 | 3 |
13.250 | 958 | 7 |
13.260 | 572 | 4 |
13.270 | 1420 | 5 |
13.280 | 1901 | 5 |
Last trade - 11.43am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online